Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials.

Title : Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials

Source : PubMed
ID : 28230450
Authors : Malatestinic, William; Nordstrom, Beth; Wu, Jashin J.; Goldblum, Orin; Solotkin, Kathleen; Lin, Chen-Yen; Kistler, Kristin; Fraeman, Kathy; Johnston, Joseph; Hawley, Lcdr Lesley; Sicignano, Nicholas; Araujo, Andre
Year : 2017
Disease Category : Skin diseases
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Eligible patients (by applying criteria) vs. ineliglble patients (by applying criteria) : Yes
Eligible patients (by applying criteria) vs. potentially eliglble patients (having treatment-related exclusion critera. Treatment may stop before enrollment, thus making them eligible) : Yes
Real-world data sources : U.S. Department of Defense health care database
Target Population Data Type Levels : National